If you want to see realistic premium for a t/o then read this report
there is an example of Tobira selling for 500% premium .... but that is a isolated case. That would give us our $15+++ but unlikely to happen.
I think $6-8 is about right
M&A 2017 biotech report
2018, page-22
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.91 |
Change
-1.180(6.90%) |
Mkt cap ! $2.010B | |||
| Open | High | Low | Value | Volume |
| $15.04 | $16.00 | $14.65 | $11.72M | 757.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 402 | $15.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.92 | 809 | 13 |
View Market Depth
| Last trade - 11.20am 09/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |